Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
Oncimmune ImmunoINSIGHTS contract signed with leading top 10 global pharmaceutical company 4 March 2022
Allergy Therapeutics results and US readiness plan underway including two pivotal trials 3 March 2022
3 FTSE 100 Stocks going ex-dividend 3rd March, Dechra Pharmaceuticals, Hargreaves Lansdown, Barclays 2 March 2022
Pennon Group strong financial position with expected cash and committed facilities in excess of £3 billion 25 September 2020
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025